These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35777925)

  • 1. The Comparative Effectiveness of Vasoactive Treatments for Hepatorenal Syndrome: A Systematic Review and Network Meta-Analysis.
    Pitre T; Kiflen M; Helmeczi W; Dionne JC; Rewa O; Bagshaw SM; Needham-Nethercott N; Alhazzani W; Zeraatkar D; Rochwerg B
    Crit Care Med; 2022 Oct; 50(10):1419-1429. PubMed ID: 35777925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.
    Facciorusso A; Chandar AK; Murad MH; Prokop LJ; Muscatiello N; Kamath PS; Singh S
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):94-102. PubMed ID: 28403995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
    Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of terlipressin for hepatorenal syndrome: the United States hospital perspective.
    Carter JA; Huang X; Jamil K; Corman S; Ektare V; Niewoehner J
    J Med Econ; 2023; 26(1):1342-1348. PubMed ID: 37729445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
    Thomson MJ; Taylor A; Sharma P; Lok AS; Tapper EB
    Dig Dis Sci; 2020 May; 65(5):1539-1548. PubMed ID: 31571102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
    Best LM; Freeman SC; Sutton AJ; Cooper NJ; Tng EL; Csenar M; Hawkins N; Pavlov CS; Davidson BR; Thorburn D; Cowlin M; Milne EJ; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013103. PubMed ID: 31513287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive Agents for Hepatorenal Syndrome: A Mixed Treatment Comparison Network Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials.
    Sridharan K; Sivaramakrishnan G
    J Gen Intern Med; 2018 Jan; 33(1):97-102. PubMed ID: 28924736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
    Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatorenal syndrome and associated outcomes: a systematic reviews.
    Roozbeh J; Ezzatzadegan Jahromi S; Rezazadeh MH; Hamidianjahromi A; Malekmakan L
    BMJ Open Gastroenterol; 2024 Apr; 11(1):. PubMed ID: 38631807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.
    Huang X; Bindra J; Chopra I; Niewoehner J; Wan GJ
    Adv Ther; 2023 Dec; 40(12):5432-5446. PubMed ID: 37812332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.
    Nanda A; Reddy R; Safraz H; Salameh H; Singal AK
    J Clin Gastroenterol; 2018 Apr; 52(4):360-367. PubMed ID: 28991106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
    Nassar Junior AP; Farias AQ; D' Albuquerque LA; Carrilho FJ; Malbouisson LM
    PLoS One; 2014; 9(9):e107466. PubMed ID: 25203311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
    Olson JC; Subramanian RM
    PLoS One; 2024; 19(1):e0296690. PubMed ID: 38285703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.
    Erstad BL
    Ann Pharmacother; 2024 Feb; 58(2):156-164. PubMed ID: 37271967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
    Gifford FJ; Morling JR; Fallowfield JA
    Aliment Pharmacol Ther; 2017 Mar; 45(5):593-603. PubMed ID: 28052382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Int J Artif Organs; 2009 Mar; 32(3):133-40. PubMed ID: 19440988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin for hepatorenal syndrome.
    Gluud LL; Christensen K; Christensen E; Krag A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD005162. PubMed ID: 22972083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
    Wang H; Liu A; Bo W; Feng X; Hu Y
    Medicine (Baltimore); 2018 Apr; 97(16):e0431. PubMed ID: 29668606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.